231 related articles for article (PubMed ID: 27521821)
1. Effect of Pycnogenol on the Healing of Venous Ulcers.
Toledo RR; Santos MERC; Schnaider TB
Ann Vasc Surg; 2017 Jan; 38():212-219. PubMed ID: 27521821
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients.
Guilhou JJ; Dereure O; Marzin L; Ouvry P; Zuccarelli F; Debure C; Van Landuyt H; Gillet-Terver MN; Guillot B; Levesque H; Mignot J; Pillion G; Février B; Dubeaux D
Angiology; 1997 Jan; 48(1):77-85. PubMed ID: 8995348
[TBL] [Abstract][Full Text] [Related]
3. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
Iablokov EG; Bogachev VIu; Domoradskaia AI
Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954
[TBL] [Abstract][Full Text] [Related]
4. Sulodexide and phlebotonics in the treatment of venous ulcer.
González Ochoa A
Int Angiol; 2017 Feb; 36(1):82-87. PubMed ID: 27310527
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study.
Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
Clin Appl Thromb Hemost; 2006 Apr; 12(2):205-12. PubMed ID: 16708123
[TBL] [Abstract][Full Text] [Related]
6. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.
Lyseng-Williamson KA; Perry CM
Drugs; 2003; 63(1):71-100. PubMed ID: 12487623
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].
Hnátek L
Vnitr Lek; 2015 Sep; 61(9):807-14. PubMed ID: 26465280
[TBL] [Abstract][Full Text] [Related]
8. Techniques used to evaluate the cutaneous microcirculation: application of photoplethysmography to the assessment of a phlebotropic agent in the treatment of leg ulcers.
Guillot B
Angiology; 1994 Jun; 45(6 Pt 2):542-8. PubMed ID: 8203785
[TBL] [Abstract][Full Text] [Related]
9. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
Amato C
Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
[TBL] [Abstract][Full Text] [Related]
10. Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.
Cazaubon M; Benigni JP; Steinbruch M; Jabbour V; Gouhier-Kodas C
Vasc Health Risk Manag; 2021; 17():591-600. PubMed ID: 34556990
[TBL] [Abstract][Full Text] [Related]
11. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
[TBL] [Abstract][Full Text] [Related]
12. [Hemorrhoids and conservative treatment. Review of the literature on the use of diosmin and micronized hesperidin].
La Torre F; Nicolai AP; Otti M
Minerva Chir; 1999 Dec; 54(12):909-16. PubMed ID: 10736998
[No Abstract] [Full Text] [Related]
13. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study.
Corsale I; Carrieri P; Martellucci J; Piccolomini A; Verre L; Rigutini M; Panicucci S
Int J Colorectal Dis; 2018 Nov; 33(11):1595-1600. PubMed ID: 29934701
[TBL] [Abstract][Full Text] [Related]
14. Daflon 500 mg and venous leg ulcer: new results from a meta-analysis.
Smith PC
Angiology; 2005; 56 Suppl 1():S33-9. PubMed ID: 16193225
[TBL] [Abstract][Full Text] [Related]
15. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
Geroulakos G; Nicolaides AN
Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
[TBL] [Abstract][Full Text] [Related]
16. Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol.
Belcaro G; Cesarone MR; Errichi BM; Ledda A; Di Renzo A; Stuard S; Dugall M; Pellegrini L; Rohdewald P; Ippolito E; Ricci A; Cacchio M; Ruffini I; Fano F; Hosoi M
Angiology; 2005; 56(6):699-705. PubMed ID: 16327946
[TBL] [Abstract][Full Text] [Related]
17. Benefit of a 2-month treatment with a micronized, purified flavonoidic fraction on venous ulcer healing. A randomized, double-blind, controlled versus placebo trial.
Guilhou JJ; Février F; Debure C; Dubeaux D; Gillet-Terver MN; Guillot B; Levesque H; Marzin L; Mignot J; Ouvry P; Pillion G; Van Landuyt H; Zuccarelli F; Nicolaïdes AN
Int J Microcirc Clin Exp; 1997; 17 Suppl 1():21-6. PubMed ID: 9477041
[TBL] [Abstract][Full Text] [Related]
18. [Chronic venous disorders - necessity of specific differentiation to determination of the best medical treatment].
Karetová D
Vnitr Lek; 2015 Sep; 61(9):762-4. PubMed ID: 26790171
[No Abstract] [Full Text] [Related]
19. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
Struckmann JR; Nicolaides AN
Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of a new drug in phlebology].
Spartera C; Santoro P; Frezzotti A; Marciani A; Ricci G
Clin Ter; 1979 Jan; 88(2):139-47. PubMed ID: 428194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
